The bivalent vaccine booster outperforms - by Eric Topol
A Bivalent Omicron-Containing Booster Vaccine against Covid-19 | NEJM
CDC publishes first estimates of bivalent boosters' effectiveness against XBB.1.5
Bivalent mRNA booster effective, 'essential' for older adults
New Omicron-specific vaccines offer similar protection to existing boosters
Efficacy of a Fourth Dose of Covid-19 mRNA Vaccine against Omicron | NEJM
A Bivalent Omicron-Containing Booster Vaccine against Covid-19 | NEJM
Early Estimates of Bivalent mRNA Booster Dose Vaccine Effectiveness in Preventing Symptomatic SARS-CoV-2 Infection Attributable to Omicron BA.5– and XBB/XBB.1.5–Related Sublineages Among Immunocompetent Adults — Increasing Community Access to Testing ...
FDA advisory panel recommends Omicron-containing booster shots
Comparative effectiveness of bivalent BA.4-5 and BA.1 mRNA booster vaccines among adults aged ≥50 years in Nordic countries: nationwide cohort study | The BMJ
Who Is Eligible for a COVID-19 Booster?
New Omicron-specific vaccines offer similar protection to existing boosters
Effectiveness of the Coronavirus Disease 2019 (COVID-19) Bivalent Vaccine | medRxiv
Updated Bivalent Boosters Offer Extra Protection Against COVID-19
Effectiveness of Bivalent mRNA Vaccines in Preventing Symptomatic SARS-CoV-2 Infection — Increasing Community Access to Testing Program, United States, September–November 2022 | MMWR
Effectiveness of a second BNT162b2 booster vaccine against hospitalization and death from COVID-19 in adults aged over 60 years | Nature Medicine
Should I get a COVID-19 booster? | Science | AAAS
COMPARISON OF COVID 19 VACCINES | Mya Care
Comparing the COVID-19 Vaccines: How Are They Different? > News > Yale Medicine
Efficacy of Bivalent Boosters Against Severe Omicron | Latest news for Doctors, Nurses and Pharmacists | Respirology
Duration of protection of ancestral-strain monovalent vaccines and effectiveness of bivalent BA.1 boosters against COVID-19 hospitalisation in England: a test-negative case-control study - The Lancet Infectious Diseases
Effectiveness of Covid-19 Vaccines over a 9-Month Period in North Carolina | NEJM
A Bivalent Omicron-Containing Booster Vaccine against Covid-19 | NEJM
